8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT05263284 · RECRUITING
Trial details
- NCT number
- NCT05263284
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2029-01-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.